Key facts
- Clearstep’s last known valuation is $15.6M (Feb 2025).
- It has raised $17.4M across 2 recorded rounds; the latest was Seed Round ($4.2M) in Dec 2024.
- Notable investors include Techstars, Astir Ventures, Startupbootcamp Holding, Makai VC, Matter (Consulting Services (B2B)) — 29 tracked in total.
- Clearstep has filed 2 Form Ds with the SEC since 2023, most recently Jan 2025 ($4.2M sold to 29 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 29 names
- ·Watchlist + deal alerts for Clearstep
Funding rounds
2 roundsAbout Clearstep
Developer of a digital healthcare platform designed to improve patient access and optimize health system capacity. The company's platform utilizes artificial intelligence and unifies clinical logic, system rules, and real-time availability to safely guide patients to the right care across digital and voice entry points, enabling healthcare institutions to streamline access, reduce call-center strain, reclaim clinical and operational capacity, and enhance patient experience.
- Sector
- Healthcare
- HQ
- Chicago, IL, United States
- Founded
- 2018
- Employees
- 29
- Website
- clearstep.health/
- Ownership
- Privately Held (backing)
Clearstep doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Clearstep shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Clearstep in its N-PORT filings yet. We sweep new filings monthly.